Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,930.00
Bid: 1,930.00
Ask: 1,938.00
Change: -20.00 (-1.03%)
Spread: 8.00 (0.415%)
Open: 1,950.00
High: 1,950.00
Low: 1,926.00
Prev. Close: 1,950.00
RCP Live PriceLast checked at -
RIT Capital Partners is an Investment Trust

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

7 Feb 2023 07:00

RNS Number : 0825P
RIT Capital Partners PLC
07 February 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

7 February 2023

 

 

December 2022 Preliminary Unaudited Net Asset Value

 

The preliminary, unaudited, diluted net asset value of RIT Capital Partners plc (the Company) as at 31 December 2022 (with debt at fair value) was 2,388p per £1 ordinary share (30 November 2022: 2,454p).

This represented a decline of -2.7% for the month of December, outperforming the MSCI ACWI (50% £) which fell -5.0% in the month. The outperformance was driven by our quoted equity book, and positive contributions from both our absolute return & credit book as well as real assets. The NAV reflected the six-monthly revaluation of our direct private investments to 31 December 2022, and, as normal, the 30 September valuations from external managers for ~94% of our private funds (with around 6% at 31 December).

 

2022 Preliminary Unaudited Performance

 

Last year was one of the most challenging years for financial markets for more than a decade, with a multitude of issues causing almost all asset classes to decline during the year. The S&P 500, the NASDAQ and the FTSE 250 closed down -18%, -32% and -17% respectively. Government bonds provided no safe harbour, with long-term US and UK bonds losing -29% and -40% respectively. Our NAV was not immune from these pressures, with a preliminary, unaudited NAV per share total return (including dividends) of -13.3% compared to the ACWI of -12.9%. With inflation at multi-year highs, our inflation measure of CPI+3.0%, was 13.5% for the year. 

Key factors impacting our return for the year were:

-

Retaining one of our lowest quoted equity exposures in a decade, coupled with action we took within the quoted equity portfolio, helped limit the downside. Nevertheless, this book saw a negative contribution of around -6.7%;

-

Private investments detracted by -6.2% of NAV, split broadly equally across the directs and funds, giving back a portion of the ~+34% NAV contribution across 2020 and 2021;

-

Our absolute return and credit book held up reasonably well, albeit with some mixed performance from our macro managers;

-

Through our currency positioning, we ensured that much of our exposure was held outside the weakening sterling, resulting in a positive contribution for the year.

While any short-term decline in NAV is uncomfortable, our aims and objectives are long term. Over the last three years our NAV returned a preliminary ~25% against the ACWI at 17.7%. Similarly, our 5-year performance of around 41% compares favourably to the ACWI at 35.5%, and over 10-years our NAV (including dividends) has grown by approximately 140%.

As normal at this stage of our year end, the preliminary NAV is an estimate and remains subject to adjustment and audit. Full details will be included in the 2022 Annual Report & Accounts, which is expected to be published at the end of February.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVVQLFBXLLBBBQ
Date   Source Headline
14th May 202411:48 amRNSDirector/PDMR Shareholding
14th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
7th May 20245:32 pmRNSDirector/PDMR Shareholding
2nd May 20246:18 pmRNSResult of AGM
1st May 202412:00 pmRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSNet Asset Value(s)
4th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20242:27 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20245:22 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSNet Asset Value(s)
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20244:56 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSFinal Results
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 202410:32 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20245:13 pmRNSDirectorate Change
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20241:31 pmRNSCompany Announcement
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSNet Asset Value(s)
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.